TABLE 4.
Effectiveness of IPTp-SP against placental malaria and adverse pregnancy outcome
| Birth outcome | IPTp-SP use | Crude OR (95%CI) | p-value | Adjusted OR (95%CI) |
P-value | |
| < 2 doses |
2 doses |
|||||
| Placental malaria | ||||||
| Negative | 148 | 174 | ||||
| Positive | 18 | 10 | 0.5 (0.2 – 1.1) | 0.067 | 0.5(0.2–1.1) | 0.08 |
| Birth weight | ||||||
| 2.5kg and above | 154 | 174 | ||||
| < 2.5kg | 12 | 10 | 0.7 (0.3 – 1.8) | 0.491 | 0.9 (0.3–2.1) | 0.73 |
| Maternal Hb-level | ||||||
| ≥ 11g/dl | 60 | 50 | ||||
| < 11g/dl | 82 | 78 | 1.1 (0.7 – 1.9) | 0.594 | 1.1 (0.7–1.8) | 0.71 |
| GA age at birth | ||||||
| ≥ 37 weeks | 144 | 180 | ||||
| <37 weeks | 22 | 4 | 0.1 (0.05 – 0.4) | 0.001 | 0.1 (0.05–0.4) | < 0.001 |
Abbreviations: GA = Gestational age; OR= odds ratio; CI = confidence interval; Hb = Haemoglobin level
*
There were 80 participants with no Hb results